Skip to main content

Public Invited to ALS Symposium on Nov. 16

Patients, families and researchers will hear the latest in research and patient care

  • Keynote speaker from Harvard to discuss stem cell research and impact on ALS
  • Internationally known ALS doctors and scientists will share clinical and research data
  • Attendees can ask questions of experts

CHICAGO –The public is invited to the Fifth Annual Les Turner Symposium on ALS and Neurorepair, beginning at 9 a.m. Monday, Nov. 16, at Prentice Women’s Hospital, 250 E. Superior St., third floor, conference room L, in Chicago.

The event is free but advance registration is required by Nov. 9.

The all-day meeting will offer an opportunity for people with amyotrophic lateral sclerosis (ALS) and their families, researchers, health care professionals and the public to learn about the latest news in ALS research and patient care from internationally recognized physicians and scientists.

The keynote speaker is Kevin Eggan, professor of stem cell and regenerative biology at Harvard University and principal investigator at the Harvard Stem Cell Institute.

The symposium is hosted by the Les Turner ALS Research and Patient Center at Northwestern Medicine, which houses three ALS research laboratories and the multidisciplinary Lois Insolia ALS Clinic. 

“At the event we will focus on ALS research, patient care and education as we celebrate the creation of the Les Turner ALS Research and Patient Center at Northwestern Medicine,” said P. Hande Ozdinler, assistant professor of neurology at Northwestern University Feinberg School of Medicine. “Symposiums like this bring scientists and clinicians together so that we generate momentum for collaborations and future advancements.”

The keynote speech will focus on Eggan’s work in the area of stem cell and reprogramming biology and its translational impact on neurodegenerative diseases such as ALS. Guests also can attend the research data blitz and clinical and research presentations.

ALS researchers from the University of Chicago, University of Illinois at Chicago as well as ALS doctors and scientists from the Les Turner ALS Research and Patient Center at Northwestern Medicine will present the latest findings in the field of ALS and answer questions from attendees.

ALS, commonly known as Lou Gehrig’s disease, is a terminal neuromuscular disease that attacks a person’s muscles, gradually robbing them of their ability to walk, speak, eat and breathe. Every 90 minutes, someone in the U.S. is diagnosed with ALS and every 90 minutes, someone in the U.S with ALS dies. There is currently no prevention or cure for ALS.  

Editor's Picks

Back to top